Benitec Biopharma Inc.
BNTC
$13.59
-$0.305-2.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.39% | 33.37% | 259.65% | -30.58% | -21.23% |
| Total Receivables | -50.00% | -98.25% | 332.08% | 0.00% | 0.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.08% | -17.44% | 228.66% | -55.77% | -26.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -3.13% | 1.59% | 384.62% | -7.14% | 7.69% |
| Total Current Assets | 15.19% | 32.24% | 259.70% | -30.92% | -21.26% |
|
|
|||||
| Total Current Assets | 15.19% | 32.24% | 259.70% | -30.92% | -21.26% |
| Net Property, Plant & Equipment | -19.55% | -20.27% | -16.70% | 19.51% | -15.07% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.28% | -6.90% | -7.45% | -11.32% | -3.64% |
| Total Assets | 14.97% | 31.73% | 248.09% | -29.76% | -21.07% |
|
|
|||||
| Total Accounts Payable | -34.33% | -33.16% | 65.77% | -68.88% | 71.40% |
| Total Accrued Expenses | -8.58% | 13.45% | -2.85% | 11.74% | 4.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.07% | -25.70% | -2.74% | 2.10% | 2.14% |
| Total Finance Division Other Current Liabilities | -37.60% | 2.38% | 58.77% | -25.88% | 4.22% |
| Total Other Current Liabilities | -37.60% | 2.38% | 58.77% | -25.88% | 4.22% |
| Total Current Liabilities | -32.15% | -7.53% | 43.26% | -40.18% | 26.73% |
|
|
|||||
| Total Current Liabilities | -32.15% | -7.53% | 43.26% | -40.18% | 26.73% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -54.74% | -35.07% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.32% | 7.89% | -- | -- | -- |
| Total Liabilities | -31.93% | -7.42% | 41.81% | -40.52% | 23.98% |
|
|
|||||
| Common Stock & APIC | 7.22% | 9.27% | 20.86% | 0.10% | 0.07% |
| Retained Earnings | -3.77% | -2.66% | -2.89% | -2.37% | -3.91% |
| Treasury Stock & Other | 30.72% | -11.32% | -6.83% | 12.29% | -22.05% |
| Total Common Equity | 18.33% | 35.84% | 310.85% | -25.66% | -30.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 18.33% | 35.84% | 310.85% | -25.66% | -30.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 18.33% | 35.84% | 310.85% | -25.66% | -30.65% |
|
|
|||||